Alnylam Pharmaceuticals
ALNY
#584
Rank
HK$268.38 B
Marketcap
HK$2,081
Share price
0.83%
Change (1 day)
44.73%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company